SoftBank’s Vision Fund returned for the $1bn funding round that valued the personal services platform operator at $15bn.

Mitsui and Nan Fung are among the backers celebrating Rallybio’s flotation on the Nasdaq Global Select Market following an $80.6m offering.

The GV-backed cardiovascular therapeutics company has priced an upsized offering on Nasdaq, with the shares closing just marginally higher on the first day.

The Sanofi Ventures-backed vaccine development company has listed on Nasdaq, with its shares rising on the first day of trading.

The ultrasound imaging technology developer backed by multiple corporates has completed a series C round that brought its overall funding to $320m.

GV was among the participants in a series C round that boosted the neurological communication technology developer's total funding to more than $360m.

Salesforce and Twilio backed the API platform developer in a series D round led by Lone Pine Capital, bringing its overall funding to $315m.

The Slack Fund-backed password management technology developer has raised a series B round that valued it at $2bn post-money.

The Verizon-backed programmatic advertising software provider is joining forces with Nasdaq-listed CAP Acquisition Corporation.

Existing investors Pfizer Ventures and Merck GHI helped the precision cancer test developer take its total funding past the $130m mark.